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The Scene expression of granulocyte colony-stimulating factor (G-CSF) is induced by lipopolysaccharidc (LPS). GPEI, a cis-controlling element 
of the GCSF gene, functions as an LPS-responsive element. GPEl-binding protein (GPEl-BP)), a leucine-zipper protein, did not independently 
activate G-CSF gene xpression, Protein blot analysis with biotinylnted GPEI-BP rev&d that there were nuclear proteins that interact specifically 
with GPEL-BP. Three lcucinc-zipper proteins were isolated from mouse cDNA expression libraries by this method: NF-IL6, ATF4, and a novel 
ATF4mrelated ATFx. The interactions of these pro&s with GPEI-BP may play key roles in G-CSF gene expression. 
Granulocyte colony-stimulating factor; Transcription factor; Leucinc zipper; Protein-protein interaction; Lipopolysaccharide 
1. INTRODUCTION 
Granulocyte colony-stimulating factor (G-CSF) is 
produced from macrophages in response to LPS [l]. In 
the mouse G-CSF gene, three c&controlling promoter 
elements are required for its constitutive xpression in 
carcinoma cells as well as for its LPS-inducible expres- 
sion in macrophage cells [I ,2]: GPEl , located at about 
- 180 base pairs upstream of the TATA box; GPEZ, an 
octamer sequence [3]; GPE3, a G-CSF-specific sequence 
[4]. GPEl was identified as an LPS-inducible regulatory 
element in the G-CSF gene promoter [l]. Footprinting 
analysis and gel retardation assay indicated that nuclear 
factors specifically bind to the proximal part (-186/ 
-161) of the GPEl. 
Previously, we isolated the cDNA for the mouse 
GPEl -binding protein GPEl-BP by Southwestern blot 
analysis [5j. This 15Q-amino acid protein has a short 
amino-terminal region followed by a basic domain and 
a leucine-zipper motif [6], which exhibits high homology 
wirh the CCAAT/enhancer-binding protein (C/EBP) 
and NF-IL6, another member of C/EBP family [7], The 
Ig(EBP, which binds to the enhancer egion of the im- 
munoglobulin gene [g], is probably identical to the 
GPE-BP, GPEl-BP mRNA is ubiquitously expressed 
regardless of LPS treatment [S]. GPEl-BP contains no 
obvious transcriptional activating domains [33, and 
transfection of GPEl-BP expression plasmid into mac- 
rophage cell lines indicated that GPEl-BP did not inde- 
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pendently activate the GPEl-mediated transcription of 
the G-CSF gene (unpublished ata). It is possible that 
the LPS-inducible expression of G-CSF gene is 
mediated by the interactions of GPEl-BP with activator 
proteins. 
In this study, protein blotting analysis using biotin- 
ylated GPEl-BP probe demonstrated that there arc nu- 
clear proteins which specifically interact with GPEl- 
BP. By screening cDNA expression libraries, three 
leucine-zipper proteins interacting with GPEl-BP were 
identified. 
2. MATERIALS AND METHODS 
The GPEI-BP cDNA [!I] was cloned into a vector pMNT con- 
structed from pGEMEX.1 (Promega) by deletion of T7 gene 10, and 
the resultant plasmid was used to produce GPEl-BP 191. The purified 
protein was biotinytated by biotin.N-hydroxysuccinilllide ester 
(Pierce). Macrophage nuclear extracts resolved by SDSpolyacryl- 
amide gel were transferred and the filter was immersed at 4’C over- 
night in blocking buffer which consisted of 5% skim milk, 2 m@ml 
bovine serum albumin, 10% Slycerol in CORE buffer (20 mM Tris- 
HCI @H 7.S), 100 mM KCI, 1 mMdithiothrcito1, and 0.1 mM EDTA). 
The filler was washed for 30 min with pretreatment bulfer (3% skim 
milk, 2 mg/ml bovine serum albumin, 10% glycerol id CORE buffer), 
incubated for 3 h in binding buffer (0.5 pgrnl biotinylated GPEI-BP, 
2% skim milk, 10% glycerol in CORE buffer), and washed for 30 min 
with 0.5% skim milk, 25 mM T&MCI (pH 7.4) and I50 mM NaCI. 
The Alter was incubated with streptavidin-conjugtd alkaline phos- 
phatase for 60 min and washed. Protein complexes were visualized by 
p-nitroblue tetrazolium and S-bromo-&chloro-3-indolyl phosphate. 
2,2. Screening of cDNA libraries 
Mouse &ttl 1 cDNA libraries [Sl were plated and incubated at 42°C 
for 3 h. Nitroallulose filters impregnated by isopropyl~o.thiogalac- 
topyranosidc were ovcrlnyed onto the plaques and incubated at 37OC 
for 4 h. The filters were processed by a similar method as described 
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FiB. 1. Protein blot analysis of macrophage nuclear extracts with 
biotinylated GEPl-BP probe. Macruphayc nuclear extracts (25~6 per 
lane) with or without LPS treatment were resolved by an 8% T, 3% 
C polyacrylaaide-tricine-SDS gel containing 6 M urea [13], trans- 
ferred onto a membrane, and incubated with biotinylated GEPI-BP 
in the absence (A) or the presence (B) of a 100-foid molar cxccss of 
non-biotinylated GPEl-BP. 
[ID] except he urea dcnaturation/renaturation step: the proteins were 
denatured by 8 M urea in CORE buffer for 20 min, and the solution 
was 2-fold diluted with CORE buffer and incubated for 5 min. The 
dilution step was repeated three times and the filters were washed for 
30 min with CORE buffer. The filters were blocked and processed as 
essentially described above. The isolated cDNA clones were cross- 
hybridized to classify them. The probe cDNAs were kindly provided 
by Dn. S. Akira, A.D. Friedman, J. Fujiaawa and P.K. Vogt. 
3. RESUL’L’Z AND DISCUSSIGN 
To examina.;he presence ofpm::eir;s that, interact with 
GPEl-BP, macrophage nuciear e:;iracts were analyzed 
by the protein blotting :x&hod using biotinylated 
GPEl-BP. As shown in Fig. 1 A, about 20 bands were 
observed. Most of them disappeared upon addition of 
a lO&fold molar excess of non-biotinylated GPEl-BP 
to the probe during the binding (Fig. ZB). These results 
demonstrated that nuclear proteins interacting speeifi- 
tally with GPEl-BP were present in the extracts. 
To isolate cDNAs encoding these proteins, itgtl 1 ex- 
pression libraries constructed from mouse BAM3 and 
PUS-l.8 cells [q were screened by the same method 
using the biotinylated GPEl-BP. 58 clones were positive 
among 2 x lo6 phages of the cDNA libraries, and these 
clones were classified into 20 groups by cross-hybridiza- 
tion of the cDNA inserts. 
A hybridization analysis was performed with various 
cDNAs which encode leucine-zipper proteins such as 
CIEBP, NF-IL6, CAMP-responsive element binding 
protein (CREB), CRE-BPl, FOS, and JUN. One posi- 
tive clone hybridized with the cDNA encoding human 
NF-IL6 [7’J The nucleo!ide sequence of the cDNA con- 
firmed that the deduced protein is the mouse coun- 
terpart of human NF-IL6, because the basic domain 
and leucine-zipper motif are highly conserved (97% 
identical) between mouse and human (Fig. 2). The 36- 
kDa NF-IL6 protein was isolated as a transcriptional 
activator which bound to the ‘NF-IL6 site’ 
(TTNNGNAAT) in the interleukin-6 gene [7). It has 
also been suggested that NF-IL6 might bind to the prox- 
imal region (- 173/- 18 1) of GPEl in G-CSF gene pro- 
moter [7] (see Fig. 3). Southwestern blot analysis re- 
vealed weak binding of NF-IL6 to GPEl (data not 
shown). 
The isolated cDNA clones which did not hybridize 
with the above-mentioned cDNA probes were subjected 
to DNA sequencing analysis. Two cDNA groups were 
revealed to contain the leucine-zipper motifs. Since the 
amino acid scqucnce of the onr: cDNA group is highly 
homologous (95% identical) to human activating tran- 
scription factor-4 (ATF4) [I 1,121, it appears to be the 
mouse counterpart of ATF4 (Fig. 2). The amino acid 
sequence of the other cDNA group is significantly re- 
lated to ATF4 (55% identity), and is likely to belong to 
the ATF family (designated as ‘ATFx’). The unique 
-feature of this novel protein is that three leucine residues 
~~~~S:~BPKKS~PMDANSBDEYRQRWIRMNMAVKKS~L~SKQKACD 
mNF.118 KAKKTVDKLSDEYKMRWlfl~# IAVtlKSmD#AKYRNLE 
hNF.ILB KA~:KTVDK~lSDEYKlR~~RUN IAVRKSflDKAKYAhLB 
mATF4 LTAKVKTEKLOKKLKKNICidKTAATRVROKKRAEOEA 
hATF4 VAAKVKOEKLPKKLKKMBPMKTAATRT~OKKRA~~EA 
mATPa PtP5PkSTROORKDKK~DPIKS~ALRT~OflKRAEOEA 
Leuclne Zipper 
mOPEI.BPTLQAVNOLKEEHOR~EAKl KLbTK~L6VLKDLFLBllAHB 
mNPdL6 TDHKYLE~TAE~PR~QRKVECLS~~A*~FIPLPBP 
hNP.116 TCHKVLB~.TAEW~RLPKKVEOLSAILSR~LSTLRNLFKCLPEP 
mATF4 LT4ECKELEKK~IALKEKADSLAK~l PYLKPLI EQYRKA 
hATF4 LTGECKELEKKWIALKERADSLAK~I PVLKDLI EUVRKA 
rnATF2 L~CICCDL~AR#RffkRERAES~@R~l CVVKDLL llV7AA ‘ . 
Fig. 2. Alignment of amino acid scque&es of the b;ic domain Ad leucine-zipper motif. The sequences for mouse NF-U-6, ATF4, and ATFx 
identified in this study are al&ted with those for mouse GPEI-BP [S], human NF-IL6 [7], and human ATF4 [12]. h, human; m, mouse. Highly 
conserved residues among these proteins arc shadowed. 
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Fig. 3. The possible binding sites of GPEl-BP, NF-IL6 and ATF in 
the GPEl sequence (from -193 to -53). They arc indicated by lines: 
GPEI-BP-binding site (-186/-161) [S], NF-IL6 site (-173/- 181), and 
ATFmlike site (-17%183). 
in the carboxy-terminal half of its leucine-zipper 
domain were substituted with three valine residues. 
Members of the ATF family bind to ‘ATF sites’ 
(GTGACGTAXA/G) in adenovirus Ela-inducible 
genes [Xl]. In agreement with the fact that an ATF-like 
site (-175/-l 83) is superimposed on the NF-IL6 site in 
the GPEl (see Fig. 3), the Southwestern blot analysis 
suggested that mouse ATF4 and ATFx could bind to 
GPEl to some extent (data not shown). 
By searching for nuclear proteins that interact with 
the leucine-zipper protein GPEl-BP, three leucine- 
zipper proteins are identified: NF-IL6, ATF4 and a 
novel ATFx. Northern hybridization showed that the 
NF-IL6 mRNA increased approximately lo-fold by 
LPS treatment in macrophages, while mRNAs for 
ATF4 and ATFLEx were ubiquitously expressed regard- 
less of LPS treatment (data not shown). These results 
suggest hat different sets of homo- and hetero-dimers 
of the leucine-zipper proteins may compete for the 
target sites on GPEl (see Fig, 3). It is noteworthy that 
our preliminary results suggested that the heterodimer 
ATF4/GPEl-BP bound more tightly to the GPEl DNA 
than ATF4 alone did (unpublished ata). During the 
inducible expression of the G-CSF gene, the binding of 
the transcription factors to the GPEl sequence may be 
modulated by the protein-protein interactions of 
GPEl-BP with other trans-activators. To clarify the 
contribution of the three leucine-zipper proteins to the 
G-CSF gene expression, it will be necessary to isolate 
full-length cDNAs and study their functions. Further 
investigation of the nuclear proteins that interact with 
GPEl-BP may elucidate the molecular mechanisms for 
LPS-inducible gene expression. 
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